| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |